Li Yaping, Ogris Manfred, Wagner Ernst, Pelisek Jaroslav, Rüffer Martina
Center of Drug Research, Department of Pharmacy, Ludwig-Maximilians-University, Butenandtstr. 5-13, D-81377 Munich, Germany.
Int J Pharm. 2003 Jun 18;259(1-2):93-101. doi: 10.1016/s0378-5173(03)00211-4.
The aims of this work were to determine the stability of pDNA against various conditions during microencapsulation, prepare transferrin (TF)-conjugated PEGylated polycyanoacrylate nanoparticles (TF-PEG-nanoparticles), and assess its physicochemical characteristics and in vitro targeting cells association. The open circular forms of pDNA obviously increased when pDNA was emulsified into organic solution under sonification. When pDNA solution (pH 7.0) contained 1, 3 or 5% (w/v) PVA, after sonification, average 48.2, 59.4 and 62.1% of double-supercoiled DNA (dsDNA) were preserved, respectively. When medium of pDNA was 0.9% NaCl (pH 7.0), 0.1M NaHCO(3) (pH 8.0) or phosphate buffer (pH 8.0), average 53.1, 69.3 and 56.9% of dsDNA remained after sonification, respectively. Poly(aminopoly(ethylene glycol)cyanoacrylate-co-hexadecyl cyanoacrylate) (poly(H(2)NPEGCA-co-HDCA)) showed a slight influence on pDNA in 0.1M NaHCO(3) (pH 8.0) when its concentration increased from 0.5 to 4% (w/v). TF-PEG-nanoparticles loading pDNA were spherical in shape with size under 200nm and entrapment efficiency 35-50%. 0.1M NaHCO(3) with 3% PVA (w/v) could largely reduce the damage of pDNA during microencapsulation. TF-PEG-nanoparticles bore 1-3% of the total PEG chains conjugated to TF molecules, and exhibited the burst effect with over 30% drug release within 1 day. After the first phase, pDNA release profiles displayed a sustained release. The amount of cumulated pDNA release over 7 days was: 86.3, 81.5 and 74.4% for 1, 2 and 4% polymer nanoparticles, respectively. The degree of target K562 cell binding of TF-PEG-nanoparticles was greater than that of non-targeted PEG-nanoparticles at 4 degrees C. The presence of free TF decreased significantly the degree of cell binding of TF-PEG-nanoparticles, which revealed that the binding of TF-PEG-nanoparticles to K562 cells was indeed receptor specific. These results suggested that TF-PEG-nanoparticles were useful for delivery of pDNA to target cells.
本研究的目的是确定微囊化过程中质粒DNA(pDNA)在各种条件下的稳定性,制备转铁蛋白(TF)偶联的聚乙二醇化聚氰基丙烯酸酯纳米粒(TF-PEG-纳米粒),并评估其理化特性及体外靶向细胞结合情况。在超声作用下将pDNA乳化到有机溶液中时,开环形式的pDNA明显增加。当pDNA溶液(pH 7.0)含有1%、3%或5%(w/v)的聚乙烯醇(PVA)时,超声处理后,分别平均保留48.2%、59.4%和62.1%的双链超螺旋DNA(dsDNA)。当pDNA的介质为0.9%氯化钠(pH 7.0)、0.1M碳酸氢钠(pH 8.0)或磷酸盐缓冲液(pH 8.0)时,超声处理后分别平均有53.1%、69.3%和56.9%的dsDNA留存。聚(氨基聚(乙二醇)氰基丙烯酸酯-共-十六烷基氰基丙烯酸酯)(聚(H₂NPEGCA-共-HDCA))在0.1M碳酸氢钠(pH 8.0)中,当其浓度从0.5%增加到4%(w/v)时,对pDNA有轻微影响。负载pDNA的TF-PEG-纳米粒呈球形,尺寸小于200nm,包封率为35 - 50%。含3%(w/v)PVA的0.1M碳酸氢钠可在很大程度上减少微囊化过程中pDNA的损伤。TF-PEG-纳米粒上与TF分子偶联的PEG链占总PEG链的1% - 3%,并在1天内表现出超过30%的药物突释效应。第一阶段后,pDNA释放曲线呈持续释放。7天内累积的pDNA释放量分别为:1%、2%和4%聚合物纳米粒的释放量分别为86.3%、81.5%和74.4%。在4℃时,TF-PEG-纳米粒对靶细胞K562的结合程度大于非靶向PEG-纳米粒。游离TF的存在显著降低了TF-PEG-纳米粒的细胞结合程度,这表明TF-PEG-纳米粒与K562细胞的结合确实具有受体特异性。这些结果表明TF-PEG-纳米粒可用于将pDNA递送至靶细胞。